🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

148,36 USD

Máx. histórico

156,45

69 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,17%

Rango 52 semanas

82,01 – 156,92

Variación hoy

-0,78%

Cierre anterior

149,52

Rango de hoy

147,12 – 150,25

Volumen hoy

9.050.917

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,42%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
149,86 (puede no estar actualizado)
Dividend yield
2,27% (puede no estar actualizado)
Precio objetivo analistas
159,91 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 20 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,29%
Fecha de pago Importe por participación
02/03/1978 0,0113 USD
28/11/1977 0,0113 USD
29/08/1977 0,0099 USD
31/05/1977 0,0099 USD
01/03/1977 0,0099 USD
30/11/1976 0,0099 USD
30/08/1976 0,0093 USD
01/06/1976 0,0093 USD
02/03/1976 0,0093 USD
01/12/1975 0,0093 USD
29/08/1975 0,0093 USD
02/06/1975 0,0093 USD
03/03/1975 0,0093 USD
30/08/1974 0,0093 USD
03/06/1974 0,0093 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
13/02/2026 121,50 123,33 121,03 121,41 +1,82% 1,89% 10.102.300
12/02/2026 119,01 121,61 118,12 119,24 -0,06% 2,93% 13.453.300
11/02/2026 117,04 119,36 116,31 119,31 +1,84% 2,61% 10.885.300
10/02/2026 117,69 118,18 116,10 117,15 -0,42% 1,77% 11.849.500
09/02/2026 121,41 121,88 116,98 117,65 -3,51% 4,04% 16.158.700
06/02/2026 120,76 122,66 120,44 121,93 +1,82% 1,84% 13.083.300
05/02/2026 118,31 122,43 118,31 119,75 +1,20% 3,48% 24.010.600
04/02/2026 116,90 120,39 116,50 118,33 +2,15% 3,33% 21.954.600
03/02/2026 111,67 118,46 111,44 115,84 +2,18% 6,29% 25.793.600
02/02/2026 110,12 113,89 109,95 113,37 +2,81% 3,58% 18.000.100
30/01/2026 108,59 110,54 107,95 110,27 +1,78% 2,39% 19.060.600
29/01/2026 107,33 109,93 107,10 108,34 +1,35% 2,64% 13.572.800
28/01/2026 106,85 107,93 106,03 106,90 -0,95% 1,78% 7.491.700
27/01/2026 107,50 108,35 106,84 107,92 +0,48% 1,40% 7.907.100
26/01/2026 107,80 108,42 107,06 107,40 -0,72% 1,26% 9.903.200
23/01/2026 109,09 109,09 107,21 108,18 -0,92% 1,72% 10.489.500
22/01/2026 110,78 111,32 108,59 109,18 -1,74% 2,46% 9.362.600
21/01/2026 109,19 111,97 108,73 111,11 +1,52% 2,97% 12.844.400
20/01/2026 108,11 109,64 106,93 109,45 +0,57% 2,51% 15.241.100
16/01/2026 110,72 110,73 108,43 108,83 -1,93% 2,08% 14.852.100
15/01/2026 110,62 111,58 108,45 110,97 -0,04% 2,83% 11.775.800
14/01/2026 108,97 111,23 107,95 111,01 +2,54% 3,01% 11.964.600
13/01/2026 109,05 109,31 107,22 108,26 -0,85% 1,92% 9.338.600
12/01/2026 110,97 111,46 108,78 109,19 -1,21% 2,42% 10.671.900
09/01/2026 110,87 112,48 110,22 110,53 -0,41% 2,04% 11.040.800
08/01/2026 110,61 112,90 109,25 110,99 +2,20% 3,30% 20.278.800
07/01/2026 109,51 111,46 107,95 108,60 -0,25% 3,21% 16.322.300
06/01/2026 107,68 110,17 107,68 108,87 +1,33% 2,31% 14.479.000
05/01/2026 107,01 108,44 105,80 107,44 +0,93% 2,47% 15.863.300
02/01/2026 105,53 106,62 104,43 106,45 +1,13% 2,08% 9.992.400